Posted by Michael Wonder on 01 Aug 2025
Serplulimab in combination with carboplatin and etoposide phosphate for the first-line treatment of patients with extensive-stage small-cell lung cancer
30 July 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use of serplulimab for use in combination with carboplatin and etoposide phosphate in the NHS in England.
For the time being, the combination of serplulimab and carboplatin and etoposide phosphate should not be used for the first-line treatment of adults with extensive-stage small-cell lung cancer.
